ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 577 out of 1844

$341K Total Retail Price of All Prescriptions

Rank: 705 out of 1844

183 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 183 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 3,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 296 130 1 1
OMEPRAZOLE 287 146 2 5
PRAVASTATIN SODIUM 218 128 3 10
RANITIDINE HCL 183 79 4 38
SIMVASTATIN 134 123 5 3
SPIRONOLACTONE 125 85 6 60
HYDROCODONE-ACETAMINOPHEN 124 54 S3 7 2
TAMSULOSIN HCL 120 55 8 27
POLYETHYLENE GLYCOL 3350 114 49 9 39
FLUOXETINE HCL 102 65 10 41
ALENDRONATE SODIUM 102 91 10 25
MELOXICAM 95 46 12 28
LISINOPRIL 93 82 13 4
METFORMIN HCL 92 48 14 8
TRAMADOL HCL 90 42 15 18
GABAPENTIN 89 58 16 15
AMLODIPINE BESYLATE 87 83 17 6
CYCLOBENZAPRINE HCL 84 21 R 18 53
ATORVASTATIN CALCIUM 83 46 19 12
SERTRALINE HCL 83 18 19 21
ATENOLOL 82 82 21 17
GLIPIZIDE ER 80 54 22 79
AZITHROMYCIN 77 62 23 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 61 24 20
FUROSEMIDE 72 53 25 7
METOPROLOL SUCCINATE 69 45 26 14
VERAPAMIL ER 66 38 27 98
METOPROLOL TARTRATE 65 40 28 11
LOVASTATIN 58 43 29 44
PANTOPRAZOLE SODIUM 58 44 29 32
NAMENDA 57 57 31 33
AMOX TR-POTASSIUM CLAVULANATE 56 37 32 139
LEVOFLOXACIN 56 38 32 78
CARVEDILOL 55 40 34 22
ISOSORBIDE MONONITRATE ER 53 43 35 59
LOSARTAN POTASSIUM 53 32 35 24
TRIAMTERENE-HCTZ 52 41 37 48
HYDROCHLOROTHIAZIDE 52 37 37 9
ZOLPIDEM TARTRATE 50 16 39 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.